FAZA PET/MR scan for stomach and esophagus cancer
Part of Cancer, Digestive system clinical trials.
This study uses a special PET/MR scan (FAZA with imaging) to better understand stomach and esophagus cancer. You may be able to join if you have eligible cancer and can safely complete the scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stomach or esophagus cancer that is newly found or has spread to other parts of the body (adenocarcinoma).
- Your kidney function test is strong enough (estimated filtration rate above 45 ml/min).
- You have no known allergy to the scan contrast dye.
- You can safely have MRI: no MRI safety issues, and you can lie flat (on your back) for at least 30 minutes.
- You are not pregnant or breastfeeding, and you can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combined PET-MRI scan can be done safely and used to help plan treatment for people with locally advanced esophageal cancer. It may improve how doctors map the cancer and plan radiation therapy, but it is mainly a feasibility (testing-setup) study.
This study uses a special combined scan (PET/MRI) to look at blood flow and tissue changes in people with severely reduced blood supply to the legs. The scan is done before and after a procedure to reopen blocked blood vessels, to understand how well treatment works.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
This trial looks at two types of scans—18F-FAPI PET/CT and MRI—to see how they compare for people with suspected or diagnosed gastric cancer. The goal is to learn which scan gives better information to help guide care.
Hear when a new Metastasized Gastro-Oesophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.